Why Target RNA Modifying Enzymes in Cancer Therapy?
Targeting RNA modifying enzymes offers a novel approach to cancer therapy by directly interfering with the post-transcriptional modifications that contribute to tumorigenesis. This strategy can be particularly effective in cancers that are driven by aberrant RNA modification pathways, offering a new avenue for treatment in cases where traditional therapies may fail.
